{"id":2844,"date":"2020-06-12T14:30:00","date_gmt":"2020-06-12T14:30:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/the-study-from-lund-published-in-nature-communications\/"},"modified":"2020-06-12T14:30:00","modified_gmt":"2020-06-12T14:30:00","slug":"the-study-from-lund-published-in-nature-communications","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/the-study-from-lund-published-in-nature-communications\/","title":{"rendered":"The study from Lund published in Nature Communications"},"content":{"rendered":"<div class=\"mfn-preamble\"><strong>According to \u00a0an article published today in the scientific journal Nature Communications, the use of the heart preservation technology developed \u00a0by Professor Stig Steen \u00a0is a safe method of preservation of hearts. This is an important step for XVIVO as well as, since the company&#39;s heart preservation products are based on this technology. The commercial rights to the technology are owned by XVIVO.<\/strong><\/div>\n<p><span><span><span><span>Today the first scientific article was published which describes the results after storage during the transport of donated hearts<\/span><span> using the method developed by Professor Stig Steen in Lund, and to which XVIVO has the commercial rights. The article was published in Nature Communications today and the article&#39;s first author is Professor Johan Nilsson. See below link for the article in full:<\/span><\/span><\/span><\/span><\/p>\n<p><span><span><span><a href=\"https:\/\/www.nature.com\/articles\/s41467-020-16782-9\" rel=\"nofollow\">https:\/\/www.nature.com\/articles\/s41467-020-16782-9<\/a><\/span><\/span><\/span><\/p>\n<p><span><span><span><span>The study describes<\/span><span> \u00a0the results for six transplant patients, that received a donated heart after it was stored during transport using the new technology. These six patients are compared with 25 patients where the donated \u00a0heart \u00a0is stored during transport with traditional cold preservation. After six months, all patients (100%) transplanted with the new technology are alive and without serious complications related to heart function or rejection. The corresponding outcome in the control group of 25 patients was 72%. The results show that the method is safe and functional for clinical application.<\/span>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><\/p>\n<p>\u00a0<\/p>\n<p><span><span>June 12, 2020<\/span><\/span><\/p>\n<p><span><span>Gothenburg<\/span><\/span><br \/>\n<span><span>XVIVO Perfusion AB (publ)<\/span><\/span><\/p>\n<div class=\"mfn-footer\">\n<p><span><span>For further information please contact:<\/span><\/span><\/p>\n<p><span><span>Christoffer Rosenblad, CFO, +1 720 616 2101, christoffer.rosenblad@xvivoperfusion.com<br \/>\nDag Andersson, CEO, +46 76 643 3031, dag.andersson@xvivoperfusion.com<\/span><\/span><br \/>\n<span><span>For further information on XVIVO Perfusion\u2019s business, please refer to the company\u2019s website, www.xvivoperfusion.com<\/span><\/span><\/p>\n<p><span><span>The information was submitted for publication, through the agency of the contact person set out above, at 4.30 pm CET on June 12, 2020.<\/span><\/span><\/p>\n<p><span><span>This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.<\/span><\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>According to \u00a0an article published today in the scientific journal Nature Communications, the use of the heart preservation technology developed&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-2844","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-lang-en","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-other","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>The study from Lund published in Nature Communications - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/the-study-from-lund-published-in-nature-communications\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The study from Lund published in Nature Communications - XVIVO\" \/>\n<meta property=\"og:description\" content=\"According to \u00a0an article published today in the scientific journal Nature Communications, the use of the heart preservation technology developed...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/the-study-from-lund-published-in-nature-communications\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/the-study-from-lund-published-in-nature-communications\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/the-study-from-lund-published-in-nature-communications\\\/\",\"name\":\"The study from Lund published in Nature Communications - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2020-06-12T14:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/the-study-from-lund-published-in-nature-communications\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/the-study-from-lund-published-in-nature-communications\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/the-study-from-lund-published-in-nature-communications\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The study from Lund published in Nature Communications\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The study from Lund published in Nature Communications - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/the-study-from-lund-published-in-nature-communications\/","og_locale":"en_US","og_type":"article","og_title":"The study from Lund published in Nature Communications - XVIVO","og_description":"According to \u00a0an article published today in the scientific journal Nature Communications, the use of the heart preservation technology developed...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/the-study-from-lund-published-in-nature-communications\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/the-study-from-lund-published-in-nature-communications\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/the-study-from-lund-published-in-nature-communications\/","name":"The study from Lund published in Nature Communications - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2020-06-12T14:30:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/the-study-from-lund-published-in-nature-communications\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/the-study-from-lund-published-in-nature-communications\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/the-study-from-lund-published-in-nature-communications\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"The study from Lund published in Nature Communications"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/2844","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=2844"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}